The First 2 Years of the European Medicines Agency's Policy on Access to Documents: Secret No Longer

被引：23
|
作者：
Doshi, Peter [2 ]
Jefferson, Tom [1 ]
机构：
[1] Cochrane Collaborat, Rome, Italy
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
来源：
JAMA INTERNAL MEDICINE | 2013年 / 173卷 / 05期
关键词：
D O I：
10.1001/jamainternmed.2013.3838
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：380 / 382
页数：4
相关论文
共 50 条
  • [31] The European Medicines Agency's plans for sharing data from clinical trials
    Groves, Trish
    Godlee, Fiona
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [32] THE EUROPEAN MEDICINES AGENCY'S STRATEGIES TO TACKLE THE CHALLENGES OF AD DRUG DEVELOPMENT
    Mantua, Valentina
    [J]. NEUROBIOLOGY OF AGING, 2016, 39 : S6 - S6
  • [33] Effect of European Medicines Agency's regulatory measures on nimesulide utilization in Portugal
    Pinto, Daniel
    Silva, Ana
    Heleno, Bruno
    Rodrigues, David Silverio
    Santos, Isabel
    Caetano, Pedro A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (06) : 630 - 637
  • [34] RUMA adopts European Medicines Agency's list of highest priority antibiotics
    不详
    [J]. VETERINARY RECORD, 2017, 180 (22) : 532 - 532
  • [35] EUROPEAN FISCAL POLICY RULES: FIRST 15 YEARS
    Prusvic, David
    [J]. POLITICKA EKONOMIE, 2010, 58 (01) : 51 - 69
  • [36] The European Central Bank's Monetary Policy during Its First 20 Years
    Hartmann, Philipp
    Smets, Frank
    [J]. BROOKINGS PAPERS ON ECONOMIC ACTIVITY, 2018, : 1 - 146
  • [37] From Access to Documents to Consumption of Information: The European Commission Transparency Policy for the TTIP Negotiations
    Coremans, Evelyn
    [J]. POLITICS AND GOVERNANCE, 2017, 5 (03): : 29 - 39
  • [38] Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's Strategy
    Hines, Philip A.
    Gonzalez-Quevedo, Rosa
    Lambert, Apolline I. O. M.
    Janssens, Rosanne
    Freischem, Barbara
    Edo, Jordi Torren
    Claassen, Ivo J. T. M.
    Humphreys, Anthony J.
    [J]. FRONTIERS IN MEDICINE, 2020, 7
  • [39] The European Medicines Agency's CHMP is conducting a safety review of topical formulations of ketoprofen
    [J]. Reactions Weekly, 2010, 1284 (1) : 2 - 2
  • [40] The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach
    Nicotera, Giuseppe
    Sferrazza, Gianluca
    Serafino, Annalucia
    Pierimarchi, Pasquale
    [J]. FRONTIERS IN MEDICINE, 2019, 6
12345